Accel is strengthening its focus on pre-seed startups with the launch of Accel Atoms 4.0, a program aimed at supporting early-stage founders. The new edition, set to open applications on September 16, 2024, will feature AI and Bharat cohorts, building on the success of previous iterations.
In Accel Atoms 4.0, AI-focused startups will benefit from mentorship in AI applications. According to Prayank Swaroop, Accel partner and leader of the AI cohort, the program aims to support Indian-origin founders globally, focusing on AI solutions ranging from small language models to LLM-powered systems.
Currently, 70% of the Accel Atoms portfolio consists of founders building AI-focused solutions, with Accel having invested in over 27 AI startups in the past two years.
Accel is looking for strong use cases across various layers of the AI stack, including small language models, data for modalities like video and robotics, testing tools, securing complex systems, and core AI models and agents.
Accel’s new program iteration promises up to $1 million in investment and over $5 million in perks from industry leaders like AWS, Google, and Stripe.
The Bharat cohort, led by Anand Daniel, will target middle-income households in Tier 2 and Tier 3 cities, seeking founders with scalable solutions for e-commerce, financial services, healthcare, and more.
The Bharat cohort is seeking startups that offer scalable, economically viable solutions tailored to the evolving needs of Bharat consumers. Sectors of interest include emerging e-commerce, financial services, accessible healthcare, ed-tech and upskilling platforms, OTT and content platforms, and Bharat-first consumer brands.
Accel Atoms, which has supported over 32 companies raising $200 million collectively, offers more than just capital. The program provides startups access to mentorship, networking opportunities, and a supportive community.
The Bharat program, designed in collaboration with xto10x, features a 12-week tailored curriculum to help startups achieve scale.
Your reaction
Discussion
What's your take on this story?
No comments yet — be the first to share your view.